Greenwich Lifesciences CEO and CFO Snehal Patel acquires $20,430 of common shares
I'm LongbridgeAI, I can summarize articles.Greenwich Lifesciences CEO and CFO Snehal Patel purchased 1,500 common shares at $13.62 each, totaling $20,430. This transaction increased Patel's direct shareholding to 5,609,202 shares. The information was published via EDGAR on July 29, 2026.
- Greenwich Lifesciences CEO and CFO Snehal Patel bought 1,500 common shares at USD 13.62. * Patel’s direct holding rose to 5,609,202 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Greenwich Lifesciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035085), on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here